• Article

"Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale

PURPOSE: To describe patient- and practice-related factors that physicians report affect their clinical decision to administer prophylactic pegfilgrastim to patients

Citation

Marion, S., Tzivelekis, S., Darden, C., Price, M., Sherif, B., Garcia, J., ... Chandler, D. (2016). "Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale. Supportive Care in Cancer, 24(9), 3889-3896. DOI: 10.1007/s00520-016-3193-3